U.S. Trade Representative Katherine Tai on Wednesday met virtually with the top executive of drugmaker Moderna (MRNA.O) to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic, Tai’s office said.
Tai and Moderna Chief Executive Stephane Bancel also discussed increasing vaccine production and global health issues, Tai’s office said in a statement.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
